Aerodynamic properties and in silico deposition of meloxicam potassium incorporated in a carrier-free DPI pulmonary system.

[1]  Rafał Gulej,et al.  Synthesis and the Biological Activity of Phosphonylated 1,2,3-Triazolenaphthalimide Conjugates , 2016, Molecules.

[2]  R. Ambrus,et al.  Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells , 2016, Molecules.

[3]  I. Balásházy,et al.  Computer Modelling as a Tool in Characterization and Optimization of Aerosol Drug Delivery , 2015 .

[4]  Anne Marie Healy,et al.  Dry powders for oral inhalation free of lactose carrier particles. , 2014, Advanced drug delivery reviews.

[5]  H. Frijlink,et al.  The clinical relevance of dry powder inhaler performance for drug delivery. , 2014, Respiratory medicine.

[6]  L. Gradon,et al.  Formation of particles for dry powder inhalers , 2014 .

[7]  R. Ambrus,et al.  Effect of polymers for aerolization properties of mannitol-based microcomposites containing meloxicam , 2013 .

[8]  R. Ambrus,et al.  Analysis of co-spray-dried meloxicam-mannitol systems containing crystalline microcomposites. , 2011, Journal of pharmaceutical and biomedical analysis.

[9]  P. Kuehl,et al.  Mechanistic models facilitate efficient development of leucine containing microparticles for pulmonary drug delivery. , 2011, International journal of pharmaceutics.

[10]  K. Amighi,et al.  Formulation strategy and use of excipients in pulmonary drug delivery. , 2010, International journal of pharmaceutics.

[11]  H. Chan,et al.  Pharmacopeial methodologies for determining aerodynamic mass distributions of ultra-high dose inhaler medicines. , 2010, Journal of pharmaceutical and biomedical analysis.

[12]  J Kristl,et al.  Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam. , 2009, International journal of pharmaceutics.

[13]  G. Simig,et al.  Manufacture of High-Purity Meloxicam via Its Novel Potassium Salt Monohydrate , 2009 .

[14]  Reinhard Vehring,et al.  Pharmaceutical Particle Engineering via Spray Drying , 2007, Pharmaceutical Research.

[15]  Reinhard Vehring,et al.  Particle formation in spray drying , 2007 .

[16]  F. Hamada,et al.  Anti-fibrotic effect of meloxicam in a murine lung fibrosis model. , 2007, European journal of pharmacology.

[17]  W. Hofmann,et al.  The Effect of Morphological Variability on Surface Deposition Densities of Inhaled Particles in Human Bronchial and Acinar Airways , 2006, Inhalation toxicology.

[18]  A. Hickey,et al.  Dry powder inhaler formulation. , 2005, Respiratory care.

[19]  Kambiz Gilani,et al.  The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine. , 2004, International journal of pharmaceutics.

[20]  Y. Kawahito,et al.  Meloxicam inhibits the growth of non-small cell lung cancer. , 2000, Anticancer research.

[21]  P. Luger,et al.  Structure and physicochemical properties of meloxicam, a new NSAID , 1996 .